Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial

Annals of Internal Medicine

Volumn 142, Issue 5, 2005, Pages 313-322

  Smith, George Davey ^a   Bracha, Yiscah ^b   Svendsen, Kenneth H ^b   Neaton, James D ^b   Haffner, Steven M ^b   Kuller, Lewis H ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DISEASE COURSE; EXERCISE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 14344257056     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-5-200503010-00006     Document Type: Article

References (52)

1. Simpson RW, Shaw JE, Zimmet PZ. The prevention of type 2 diabetes - lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract. 2003;59:165-80.
2. Stern MP. Kelly West Lecture. Primary prevention of type II diabetes mellitus. Diabetes Care. 1991;14:399-410.
3. Zimmet PZ. Challenges in diabetes epidemiology - from West to the rest. Diabetes Care. 1992;15232-52.
4. Manson JE, Spelsberg A. Primary prevention of non-insulin-dependent diabetes mellitus. Am J Prev Med. 1994;10:172-84.
5. Eriksson J, Taimela S, Koivisto VA. Exercise and the metabolic syndrome. Diabetologia. 1997;40:125-35.
6. Marshall JA, Hamman RF, Baxter J. High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol. 1991;134:590-603.
7. Knowler WC, Narayan KM, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, et al. Preventing non-insulin-dependent diabetes. Diabetes. 1995;44:483-8.
8. Wang XL, Kita K, Takahashi S, Hasegawa R, Chi XJ, Yamamori H, et al. Protease activity induced by nicotine in human cells. Int J Mol Med. 1999;4:537-40.
9. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50.
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
11. Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care. 1998;21:350-9.
12. Shaten BJ, Davey Smith G, Kuller LH, Neaton JD. Risk factors for the development of type II diabetes among men enrolled in the usual care group of the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:1331-9.
13. Eberly LE, Cohen JD, Prineas R, Yang L. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care. 2003;26:848-54.
14. Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial Group. J Chronic Dis. 1977;30:261-75.
15. Sherwin R, Kaelber CT, Kezdi P, Kjelsberg MO, Thomas HE Jr. The multiple risk factor intervention trial (MRFIT) II. The development of the protocol. Prev Med. 1981;10:402-25.
16. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 1982;248:1465-77.
17. Neaton JD, Grimm RH Jr, Cutler JA. Recruitment of participants for the multiple risk factor intervention trial (MRFIT). Control Clin Trials. 1987;8:41S-53S.
18. Widdowson GM, Kuehneman M, DuChene AG, Hulley SB, Cooper GR. Quality control of biochemical data in the Multiple Risk Factor Intervention Trial: Central Laboratory. Control Clin Trials. 1986;7:17S-33S.
19. Roberts J. Weight by Height and Age of Adults: United States, 1960-1962. Vital and Health Statistics Series. Public Health Service publication no. 1000, series 11, no. 14. Washington, DC: National Center for Health Statistics; May 1966.
20. Young CM. Dietary method. In: Committee on Food Consumption Patterns, Food and Nutrition Board. Assessing Changing Food Consumption Patterns. Washington, DC: National Academy Pr; 1981.
21. Stamler J, Caggiula AW, Cutler JA, Dolecek TA, Grandits GA, Kjelsberg MO, Tillotson JL, eds. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr. 1997;65:183S-402S.
22. Caggiula AW, Christakis G, Farrand M, Hulley SB, Johnson R, Lasser NL, et al. The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids. Prev Med. 1981;10:443-75.
23. Supplement 1. American Diabetes Association: clinical practice recommendations 2000. Diabetes Care. 2000;23 Suppl 1:S1-116.
24. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: J Wiley; 1980.
25. Diggle PJ, Liang KY, Zegere SL. Analysis of Longitudinal Data. Oxford, United Kingdom: Claredon Pr; 1994.
26. Sterne JA, Davey Smith G. Sifting the evidence-what's wrong with significance tests? BMJ. 2001;322:226-31.
27. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
28. Zimmet PZ. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care. 1995;18:1050-64.
29. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-30.
30. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995;310:555-9.
31. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet. 1981;2:1303-10.
32. Hjermann I, Leren P, Norman N, Helgeland A, Holme I. Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study. Scand J Clin Lab Invest. 1980;40:89-94.
33. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. Family Heart Study Group. BMJ. 1994;308:313-20.
34. Miettinen TA, Huttunen JK, Naukkarinen V, Strandberg T, Mattila S, Kumlin T, et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. JAMA. 1985;254:2097-102.
35. Lithell H. Insulin resistance and cardiovascular drugs. Clin Exp Hypertens A. 1992;14:151-62.
36. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA. 1995;274:1915-21.
37. Hellénius ML, Brismar KE, Berglund BH, de Faire UH. Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men. J Intern Med. 1995;238:121-30.
38. Hellénius ML, de Faire U, Berglund B, Hamsten A, Krakau I. Diet and exercise are equally effective in reducing risk for cardiovascular disease. Results of a randomized controlled study in men with slightly to moderately raised cardiovascular risk factors. Atherosclerosis. 1993;103:81-91.
39. Hansen BC, Bodkin NL. Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes. 1993;42:1809-14.
40. Lane MA, Ball SS, Ingram DK, Cutler RG, Engel J, Read V, et al. Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol. 1995;268:E941-8.
41. Keen H, Jarrett RJ, McCartney P. The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia. 1982;22:73-8.
42. Jarrett RJ, Keen H, McCartney P. The Whitehall Study: ten year follow-up report on men with impaired glucose tolerance with reference to worsening to diabetes and predictors of death. Diabet Med. 1984;1:279-83.
43. Jarrett RJ, Keen H, Murrells T. Changes in blood pressure and body weight over ten years in men selected for glucose intolerance. J Epidemiol Community Health. 1987;41:145-51.
44. Page RC, Harnden KE, Walravens NK, Onslow C, Sutton P, Levy JC, et al. 'Healthy living' and sulphonylurea therapy have different effects on glucose tolerance and risk factors for vascular disease in subjects with impaired glucose tolerance. QJ Med. 1993;86:145-54.
45. Sartor G, Scherstén B, Carlström S, Melander A, Nordén A, Persson G. Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes. 1980;29:41-9.
46. Melander A. Review of previous impaired glucose tolerance intervention studies. Diabet Med. 1996;13:S20-2.
47. Eriksson KF, Lingarde F. Prevention of type II (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance. Ann Med. 1996;28:445-9.
48. O'Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984;33:596-603.
49. Shintani TT, Hughes CK, Beckham S, O'Connor HK. Obesity and cardiovascular risk intervention through the ad libitum feeding of traditional Hawaiian diet. Am J Clin Nutr. 1991;53:1647S-1651S.
50. O'Dea K. Westernisation, insulin resistance and diabetes in Australian aborigines. Med J Aust. 1991;155:258-64.
51. Ohlson LO, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055-8.
52. Koh-Banerjee P, Wang Y, Hu FB, Spiegelman D, Willett WC, Rimm EB. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol. 2004;159:1150-9.